BRIEF published on 07/24/2026 at 10:01, 17 days 2 hours ago BlackRock Inc. reduces its stake in IPSEN SA Voting Rights Actions BlackRock Threshold Crossing Ipsen SA
BRIEF published on 07/24/2026 at 10:01, 17 days 2 hours ago BlackRock Inc. réduit sa participation dans IPSEN SA Droits De Vote Franchissement De Seuil Actions BlackRock Ipsen SA
PRESS RELEASE published on 07/24/2026 at 09:56, 17 days 3 hours ago Franchissement de seuil BlackRock Inc. declares crossing below 5% threshold in IPSEN SA capital and voting rights on July 6, 2026 Déclaration BlackRock Inc. Threshold Crossing Ipsen SA Capital Decrease
BRIEF published on 07/24/2026 at 07:05, 17 days 5 hours ago Mise à jour sur l'essai BOLD de phase III d'Ipsen dans l'atrésie des voies biliaires Recherche Clinique Odevixibat Atrésie Des Voies Biliaires Essai BOLD De Phase III Transplantation Hépatique
BRIEF published on 07/24/2026 at 07:05, 17 days 5 hours ago Update on Ipsen's Phase III BOLD Trial in Biliary Atresia Clinical Research Biliary Atresia Phase III BOLD Trial Odevixibat Liver Transplantation
PRESS RELEASE published on 07/24/2026 at 07:00, 17 days 5 hours ago Ipsen fait le point sur l'essai de Phase III BOLD dans l'atrésie des voies biliaires Ipsen annonce que l'essai de Phase III BOLD pour l'atrésie des voies biliaires n'a pas atteint son critère principal. Les données confirment le profil de sécurité de l'odévixibat Ipsen Essai De Phase III Odevixibat Atrésie Des Voies Biliaires BOLD
PRESS RELEASE published on 07/24/2026 at 07:00, 17 days 5 hours ago Ipsen provides update on Phase III BOLD trial in biliary atresia Ipsen's Phase III BOLD trial for biliary atresia did not meet primary endpoint. Bylvay safety profile confirmed. Insights gained will aid future research and patient care Ipsen Biliary Atresia Phase III BOLD Trial Bylvay Pediatric Liver Transplant
BRIEF published on 07/09/2026 at 07:05, 1 month 1 day ago Dysport® franchit une étape importante dans les essais de phase III sur la migraine Essais De Phase III Dysport Migraine Épisodique Migraine Chronique Toxine Botulique
BRIEF published on 07/09/2026 at 07:05, 1 month 1 day ago Dysport® Achieves Milestone in Migraine Phase III Trials Phase III Trials Dysport Episodic Migraine Chronic Migraine Botulinum Toxin
BRIEF published on 07/09/2026 at 07:05, 1 month 1 day ago Résultats Positifs en Phase III pour Dysport® dans le Traitement de la Migraine Phase III Dysport Migraine Épisodique Migraine Chronique Toxine Botulinique
Published on 08/10/2026 at 11:00, 1 hour 57 minutes ago Blue Lagoon Announces C$10 Million Strategic Investment by Nicola Mining and Ocean Partners
Published on 08/10/2026 at 08:00, 4 hours 57 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 4 hours 57 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 13 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/10/2026 at 12:15, 42 minutes ago Brödernas Group AB (publ) resolves to delist its outstanding senior secured bonds 2024/2029 (ISIN: NO0013250597) from Frankfurt Stock Exchange
Published on 08/10/2026 at 11:35, 1 hour 21 minutes ago SOLIZE PARTNERS and Dassault Systèmes Form Partnership to Accelerate Digital Transformation in Manufacturing
Published on 08/10/2026 at 11:28, 1 hour 28 minutes ago Aroundtown SA: Release of a capital market information
Published on 08/10/2026 at 11:53, 1 hour 3 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:53, 1 hour 3 minutes ago GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026
Published on 08/10/2026 at 11:36, 1 hour 20 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 11:36, 1 hour 20 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 3 au 7 août 2026
Published on 08/10/2026 at 09:47, 3 hours 9 minutes ago 260810 BENETEAU Transactions sur actions propres
